The lack of histamine release with cisatracurium: A double-blind comparison with vecuronium

Anesthesia and Analgesia

Volumn 84, Issue 3, 1997, Pages 623-628

  Doenicke, Alfred ^a   Soukup, Jens ^b   Hoernecke, Rainer ^a   Moss, Jonathan ^c  

^a UNIVERSITY OF MUNICH   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATRACURIUM BESILATE; HISTAMINE; ISOFLURANE; LORMETAZEPAM; MUSCLE RELAXANT AGENT; NITROUS OXIDE; THIOPENTAL; TRYPTASE; VECURONIUM;

ANESTHESIA INDUCTION; ARTICLE; BLOOD PRESSURE; BOLUS INJECTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ERYTHEMA; FLUSHING; HEART RATE; HEMODYNAMICS; HISTAMINE BLOOD LEVEL; HISTAMINE RELEASE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; NEUROMUSCULAR BLOCKING; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ATRACURIUM; BLOOD PRESSURE; DOUBLE-BLIND METHOD; HEART RATE; HISTAMINE RELEASE; HUMANS; PROSPECTIVE STUDIES; THIOPENTAL; VECURONIUM BROMIDE;

EID: 0031046665     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199703000-00030     Document Type: Article

References (23)

1. Belmont MR, Lien CA, Quessy ST, et al. The clinical neuromuscular pharmacology of 51W89 in patients receiving nitrous oxide/opioid/barbiturate anesthesia. Anesthesiology 1995;82: 1139-45.
2. Lien CA, Belmont MR, Abalos A, et al. The cardiovascular effects and histamine-releasing properties of 51W89 in patients receiving nitrous oxide/opioid/barbiturate anesthesia. Anesthesiology 1995;81:1131-8.
3. Konstadt SN, Reich DL, Stanley TE III, et al. A two-center comparison of the cardiovascular effects of cisatracurium (Nimbex™) and vecuronium in patients with coronary artery disease. Anesth Analg 1995;81:1010-4.
4. Savarese JJ, Viby-Mogensen J, Reich D, Van Aken H. The haemodynamic profile of cisatracurium. Curr Opin Anaesth 1996; 9(1 Suppl):S34-9.
5. Levy JH, Brister NW, Shearin A, et al. Wheal and flare responses to opioid in humans. Anesthesiology 1989;70:756-60.
6. Doenicke A, Moss J, Lorenz W, et al. Are hypotension and rash after atracurium really caused by histamine release? Anesth Analg 1994;78:967-72.
7. Laroche D, Vergnaud MC, Sillard B, et al. Biochemical markers of anaphylactoid reactions to drugs. Anesthesiology 1991;75: 945-9.
8. McBride P, Bradley D, Kaliner M. Evaluation of a radioimmunoassay for histamine measurement in biological fluids. J Allergy Clin Immunol 1988;82:638-46.
9. Moss J. The impact of histamine research on clinical anesthesia and surgery. Agents Actions 1992;C135-48.
10. Enander I, Matsson P, Nystrand J, et al. A new radioimmunoassay for human mast cell tryptase using monoclonal antibodies. J Immunol Methods 1991;138:39-46.
11. Cannon JE, Fahey MR, Moss J, Miller RD. Vecuronium: the effect of large intravenous doses on plasma histamine. Can J Anaesth 1988;35:350-3.
12. Doenicke A, Moss J, Lorenz W, Hoernecke R. Morphine IV and nalbuphine IV cause histamine and catecholamine increase without relevant hemodynamic changes. Clin Pharmacol Ther 1995;58:81-9.
13. Ostwald P, Doenicke A, Moss J. New aspects in perioperative histamine release in anesthesia. Curr Opin Anaesth 1995;8: 489-94.
14. Stellato C, de Paulis A, Cirillo R, et al. Heterogeneity of human mast cells and basophils in response to muscle relaxants. Anesthesiology 1991;74:1078-86.
15. Marone G, Stellato C, Mastronardi P, Mazzarella B. Mechanisms of activation of human mast cells and basophils by general anesthetic drugs. Ann Fr Anesth Reanim 1993;12:116-25.
16. Stellato C, Casalaro V, Ciccarelli A, et al. General anaesthetics induce only histamine release selectively from human mast cells. Br J Anaesth 1991;67:751-8.
17. Stellato C, Cirillo R, de Paulis A, et al. Human basophil/mast cell releasability. Anesthesiology 1992;77:932-40.
18. Hermens JM, Ebertz JM, Hannifin JM, Hirshman CA. Comparison of histamine release in human skin mast cells induced by morphine, fentanyl, and oxymorphone. Anesthesiology 1985;62: 124-9.
19. Lawrence ID, Warmer JA, Cohan VL, et al. Purification and characterization of human skin mast cells. J Immunol 1987;139: 3062-9.
20. Laroche D, Lefrancois C, Gerard JL, et al. Early diagnosis of anaphylactic reactions to neuromuscular blocking drugs. Br J Anaesth 1992;69:611-4.
21. Kumar AA, Thys J, Van Aken HK, et al. Severe anaphylactic shock after atracurium. Anesth Analg 1993;76:423-5.
22. Morris RB, Cahalan MK, Miller RD, et al. The cardiovascular effects of vecuronium (ORG NC45) and pancuronium in patients undergoing coronary artery bypass grafting. Anesthesiology 1983;58:438-40.
23. Cooper RA, Maddineni VR, Mirakhur RK, et al. Time course of neuromuscular effects and pharmacokinetics of rocuronium bromide (ORG 9426) during isoflurane anaesthesia in patients with and without renal failure. Br J Anaesth 1993;71:222-6.